Literature DB >> 16480676

Adrenocortical hypertension.

Angelo Capricchione1, Nathaniel Winer, James R Sowers.   

Abstract

Primary aldosteronism, congenital adrenal hyperplasia, Cushing's syndrome, glucocorticoid-remediable aldosteronism, and corticotropin-dependent forms of adrenal pathology can cause hypertension by excessive production of adrenocortical hormones. Although traditional biochemical assays continue to be used, genetic testing has simplified the diagnosis of glucocorticoid-remediable aldosteronism. Also new interventional radiologic approaches for the diagnosis and treatment of corticotropin-dependent forms of Cushing's syndrome are available. Medical and surgical approaches, however, still remain viable options for treatment.

Entities:  

Year:  2006        PMID: 16480676     DOI: 10.1007/s11934-006-0045-6

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  56 in total

1.  Aldosteronomas: experience with superselective adrenal arterial embolization in 33 cases.

Authors:  Hirofumi Hokotate; Hiroki Inoue; Yasutaka Baba; Shinsaku Tsuchimochi; Masayuki Nakajo
Journal:  Radiology       Date:  2003-04-03       Impact factor: 11.105

2.  Stimulation and suppression of aldosterone secretion in patients with an aldosterone-producing adenoma.

Authors:  P E Slaton; M Schambelan; E G Biglieri
Journal:  J Clin Endocrinol Metab       Date:  1969-02       Impact factor: 5.958

3.  Cushing's syndrome--killing disease: discriminatory value of signs and symptoms aiding early diagnosis.

Authors:  E J Ross; D C Linch
Journal:  Lancet       Date:  1982-09-18       Impact factor: 79.321

Review 4.  Congenital adrenal hyperplasia: 11beta-hydroxylase deficiency.

Authors:  Michael Peter
Journal:  Semin Reprod Med       Date:  2002-08       Impact factor: 1.303

5.  An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing's syndrome by clinical features, biochemical tests and radiological findings.

Authors:  S B Blunt; L M Sandler; J M Burrin; G F Joplin
Journal:  Q J Med       Date:  1990-11

6.  High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives.

Authors:  Ermanno Rossi; Giuseppe Regolisti; Aurelio Negro; Carlo Sani; Simona Davoli; Franco Perazzoli
Journal:  Am J Hypertens       Date:  2002-10       Impact factor: 2.689

7.  Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia.

Authors:  B I Cerame; R S Newfield; L Pascoe; K M Curnow; S Nimkarn; T F Roe; M I New; R C Wilson
Journal:  J Clin Endocrinol Metab       Date:  1999-09       Impact factor: 5.958

8.  Malignant hypertension due to an aldosterone producing adrenal adenoma.

Authors:  B F Murphy; J A Whitworth; P Kincaid-Smith
Journal:  Clin Exp Hypertens A       Date:  1985

9.  Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway.

Authors:  N Yokota; B G Bruneau; M L Kuroski de Bold; A J de Bold
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  A nonsteroidal glucocorticoid receptor antagonist.

Authors:  Jeffrey N Miner; Curtis Tyree; Junlian Hu; Elaine Berger; Keith Marschke; Masaki Nakane; Michael J Coghlan; Dave Clemm; Ben Lane; Jon Rosen
Journal:  Mol Endocrinol       Date:  2003-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.